Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Felwick

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 31, 2007
A case of cerebral amyloid angiopathyRichard Felwick, Khaled Amar
Biomarkers in Medicine|September 8, 2018
Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkersIftikhar Ahmed, Zafar Niaz, Frederick Ewbank, et al.
Inflammatory Bowel Diseases|April 7, 2015
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilitiesSimon R Whiteoak, Richard Felwick, Tilman Sanchez-Elsner, et al.
BMJ Open Gastroenterology|November 20, 2020
Life in lockdown: experiences of patients with IBD during COVID-19Richard James Harris, Louise Downey, Trevor R Smith, et al.
Frontline Gastroenterology|March 6, 2020
Early real-world effectiveness of ustekinumab for Crohn's diseaseRichard James Harris, Martin McDonnell, David Young, et al.
Journal of Crohn'S & Colitis|December 22, 2021
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]Esther Ventress, David Young, Sohail Rahmany, et al.
Frontline Gastroenterology|October 17, 2022
Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation studyMatthew Stammers, Sohail Rahmany, Louise Downey, et al.
BMJ Open Gastroenterology|November 14, 2020
High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learningMartin McDonnell, Richard J Harris, Florina Borca, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 31, 2007
A case of cerebral amyloid angiopathyRichard Felwick, Khaled Amar
Biomarkers in Medicine|September 8, 2018
Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkersIftikhar Ahmed, Zafar Niaz, Frederick Ewbank, et al.
Inflammatory Bowel Diseases|April 7, 2015
MicroRNAs in inflammatory bowel diseases: paradoxes and possibilitiesSimon R Whiteoak, Richard Felwick, Tilman Sanchez-Elsner, et al.
BMJ Open Gastroenterology|November 20, 2020
Life in lockdown: experiences of patients with IBD during COVID-19Richard James Harris, Louise Downey, Trevor R Smith, et al.
Frontline Gastroenterology|March 6, 2020
Early real-world effectiveness of ustekinumab for Crohn's diseaseRichard James Harris, Martin McDonnell, David Young, et al.
Journal of Crohn'S & Colitis|December 22, 2021
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]Esther Ventress, David Young, Sohail Rahmany, et al.
Frontline Gastroenterology|October 17, 2022
Impact of direct-access IBD physician delivered endoscopy on clinical outcomes: a pre-implementation and post-implementation studyMatthew Stammers, Sohail Rahmany, Louise Downey, et al.
BMJ Open Gastroenterology|November 14, 2020
High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learningMartin McDonnell, Richard J Harris, Florina Borca, et al.
Pageof 1